Panagora Asset Management Inc Orgenesis Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$3.88 - $7.46 $39,222 - $75,413	-10,109 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$5.3 - $8.66 $3,100 - $5,066	-585 Reduced 5.47%	10,109 $56,000
Q2 2018 Aug 14, 2018	BUY	$8.36 - $10.72 $50,728 - $65,048	6,068 Added 131.17%	10,694 $93,000
Q1 2018 May 15, 2018	BUY	$5.0 - $14.68 $23,130 - $67,909	4,626 New	4,626 $47,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.